AU577303B2 - 9-substituted-2-amino purines - Google Patents

9-substituted-2-amino purines

Info

Publication number
AU577303B2
AU577303B2 AU31973/84A AU3197384A AU577303B2 AU 577303 B2 AU577303 B2 AU 577303B2 AU 31973/84 A AU31973/84 A AU 31973/84A AU 3197384 A AU3197384 A AU 3197384A AU 577303 B2 AU577303 B2 AU 577303B2
Authority
AU
Australia
Prior art keywords
substituted
amino purines
purines
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU31973/84A
Other versions
AU3197384A (en
Inventor
Michael Raymond Harnden
Richard Lewis Jarvest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838322199A external-priority patent/GB8322199D0/en
Priority claimed from GB838325271A external-priority patent/GB8325271D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU3197384A publication Critical patent/AU3197384A/en
Application granted granted Critical
Publication of AU577303B2 publication Critical patent/AU577303B2/en
Assigned to NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD reassignment NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD Alteration of Name(s) in Register under S187 Assignors: BEECHAM GROUP PLC
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

AU31973/84A 1983-08-18 1984-08-16 9-substituted-2-amino purines Expired AU577303B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB838322199A GB8322199D0 (en) 1983-08-18 1983-08-18 Pharmaceutical composition
GB8322199 1983-08-18
GB838325271A GB8325271D0 (en) 1983-09-21 1983-09-21 Compounds
GB8325271 1983-09-21

Publications (2)

Publication Number Publication Date
AU3197384A AU3197384A (en) 1985-02-21
AU577303B2 true AU577303B2 (en) 1988-09-22

Family

ID=26286773

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31973/84A Expired AU577303B2 (en) 1983-08-18 1984-08-16 9-substituted-2-amino purines

Country Status (1)

Country Link
AU (1) AU577303B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623667B2 (en) * 1988-07-23 1992-05-21 Novartis International Pharmaceutical Ltd A process for the preparation of 2-amino purine derivatives

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582399D1 (en) * 1984-09-20 1991-05-08 Beecham Group Plc PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USE.
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates
US6207650B1 (en) * 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
AU8702082A (en) * 1981-08-11 1983-05-05 Wellcome Foundation Limited, The Antiviral purine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
AU8702082A (en) * 1981-08-11 1983-05-05 Wellcome Foundation Limited, The Antiviral purine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623667B2 (en) * 1988-07-23 1992-05-21 Novartis International Pharmaceutical Ltd A process for the preparation of 2-amino purine derivatives

Also Published As

Publication number Publication date
AU3197384A (en) 1985-02-21

Similar Documents

Publication Publication Date Title
AU2936184A (en) 13alpha-gonanes
AU2773884A (en) Pyridyl- and pyrimidyl- sulphonamides
AU2810384A (en) Nivamaler
AU2836184A (en) Desensitiser
AU2670684A (en) N-aryl-alpha-amino-carboxamides
AU2768784A (en) Carry-cot
AU2867284A (en) Korpertrainingsgerat
AU2809484A (en) N-pyridylindoles
AU2478684A (en) Branch-copolymers
AU2449484A (en) N-piperazinylalkanoylanilides
AU4081185A (en) Purines
AU2692984A (en) Benzoquinolizines
AU2743684A (en) 4-phenyl-tetrahydro-furano-pyridines
AU2952484A (en) 6-deoxyanthracyclines
AU577303B2 (en) 9-substituted-2-amino purines
AU2445584A (en) D-homosteroids
AU2543484A (en) Sky-light
AU2917784A (en) Thiazolo - and thiazinobenzimidazoles
AU2454184A (en) Aroylimidazolones
AU2580684A (en) Pyridyl-benzoxazines
AU2814784A (en) Larmsystem
AU2682284A (en) Diphenylazomethines
AU2610884A (en) Benzobisoxazinetetra-ones
AU2745984A (en) N-cyclohexadienyl-chloroacetamides
AU2923884A (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-2-propanols

Legal Events

Date Code Title Description
NDB Extension of term for standard patent granted (sect.76)

Free format text: 20090816

PC Assignment registered

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD

Free format text: FORMER OWNER WAS: BEECHAM GROUP PLC